- /
- Supported exchanges
- / DU
- / JNJ.DU
Johnson & Johnson (JNJ DU) stock market data APIs
Johnson & Johnson Financial Data Overview
There is no Profile data available for JNJ.DU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Johnson & Johnson data using free add-ons & libraries
Get Johnson & Johnson Fundamental Data
Johnson & Johnson Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Johnson & Johnson News
New
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
Johnson & Johnson's JNJ MedTech division, which spans orthopedics, surgery, cardiovascular and vision care, contributes roughly 36% to the company’s total revenues. J&J is repositioning its MedTech...
Why Johnson & Johnson (JNJ) Is One of the Best Pharma Stocks to Invest in Now
Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in now. Johnson & Johnson (NYSE:JNJ) announced on March 28 that randomized controlled trial (RCT) data presented at the America...
Is It Too Late To Consider Johnson & Johnson (JNJ) After Its 61% One-Year Surge?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Investors may be wondering ...
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal
Johnson & Johnson (NYSE:JNJ) is included among the 13 Best Diversified Dividend Stocks to Buy Right Now.Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal On March 30, Reuters report...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.